M&A Deal Summary

Codex DNA Acquires Eton Bio

On November 9, 2021, Codex DNA acquired medical products company Eton Bio for 13M USD

Acquisition Highlights
  • This is Codex DNA’s 1st transaction in the Medical Products sector.
  • This is Codex DNA’s largest (disclosed) transaction.
  • This is Codex DNA’s 1st transaction in the United States.
  • This is Codex DNA’s 1st transaction in California.

M&A Deal Summary
Date 2021-11-09
Target Eton Bio
Sector Medical Products
Buyer(s) Codex DNA
Deal Type Add-on Acquisition
Deal Value 13M USD

Target

Eton Bio

San Diego, California, United States
Eton Bio is a biotech company specializing in DNA sequencing and oligo synthesis solutions. The company offers DNA sequencing services and products such as antibodies, peptides, metabolism assay kits, and more. Eton Bio was founded in 2003 and is based in San Diego, California.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Codex DNA

San Diego, California, United States
Category Company
Founded 2011
Sector Medical Products
Employees108
Revenue 6M USD (2020)
DESCRIPTION

Codex DNA is building biology. Creators of the BioXp system, the world’s only fully automated gene synthesis platform, and the industry-standard Gibson Assembly method, Codex DNA is focused on enabling researchers with the tools they need to rapidly and securely design, code and create synthetic DNA. Codex DNA was incorporated in 2011 and is headquartered in San Diego, California.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal